445 related articles for article (PubMed ID: 31907987)
1. A locked immunometabolic switch underlies TREM2 R47H loss of function in human iPSC-derived microglia.
Piers TM; Cosker K; Mallach A; Johnson GT; Guerreiro R; Hardy J; Pocock JM
FASEB J; 2020 Feb; 34(2):2436-2450. PubMed ID: 31907987
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's disease-associated R47H TREM2 increases, but wild-type TREM2 decreases, microglial phagocytosis of synaptosomes and neuronal loss.
Popescu AS; Butler CA; Allendorf DH; Piers TM; Mallach A; Roewe J; Reinhardt P; Cinti A; Redaelli L; Boudesco C; Pradier L; Pocock JM; Thornton P; Brown GC
Glia; 2023 Apr; 71(4):974-990. PubMed ID: 36480007
[TBL] [Abstract][Full Text] [Related]
3. TREM2 Alzheimer's variant R47H causes similar transcriptional dysregulation to knockout, yet only subtle functional phenotypes in human iPSC-derived macrophages.
Hall-Roberts H; Agarwal D; Obst J; Smith TB; Monzón-Sandoval J; Di Daniel E; Webber C; James WS; Mead E; Davis JB; Cowley SA
Alzheimers Res Ther; 2020 Nov; 12(1):151. PubMed ID: 33198789
[TBL] [Abstract][Full Text] [Related]
4. Microglial signalling pathway deficits associated with the patient derived R47H TREM2 variants linked to AD indicate inability to activate inflammasome.
Cosker K; Mallach A; Limaye J; Piers TM; Staddon J; Neame SJ; Hardy J; Pocock JM
Sci Rep; 2021 Jun; 11(1):13316. PubMed ID: 34172778
[TBL] [Abstract][Full Text] [Related]
5. iPSC-derived microglia carrying the TREM2 R47H/+ mutation are proinflammatory and promote synapse loss.
Penney J; Ralvenius WT; Loon A; Cerit O; Dileep V; Milo B; Pao PC; Woolf H; Tsai LH
Glia; 2024 Feb; 72(2):452-469. PubMed ID: 37969043
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's Risk Gene TREM2 Determines Functional Properties of New Type of Human iPSC-Derived Microglia.
Reich M; Paris I; Ebeling M; Dahm N; Schweitzer C; Reinhardt D; Schmucki R; Prasad M; Köchl F; Leist M; Cowley SA; Zhang JD; Patsch C; Gutbier S; Britschgi M
Front Immunol; 2020; 11():617860. PubMed ID: 33613545
[TBL] [Abstract][Full Text] [Related]
7. Triggering Receptor Expressed on Myeloid Cell 2 R47H Exacerbates Immune Response in Alzheimer's Disease Brain.
Korvatska O; Kiianitsa K; Ratushny A; Matsushita M; Beeman N; Chien WM; Satoh JI; Dorschner MO; Keene CD; Bammler TK; Bird TD; Raskind WH
Front Immunol; 2020; 11():559342. PubMed ID: 33101276
[TBL] [Abstract][Full Text] [Related]
8. Prior activation state shapes the microglia response to antihuman TREM2 in a mouse model of Alzheimer's disease.
Ellwanger DC; Wang S; Brioschi S; Shao Z; Green L; Case R; Yoo D; Weishuhn D; Rathanaswami P; Bradley J; Rao S; Cha D; Luan P; Sambashivan S; Gilfillan S; Hasson SA; Foltz IN; van Lookeren Campagne M; Colonna M
Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33446504
[TBL] [Abstract][Full Text] [Related]
9. Plaque-associated human microglia accumulate lipid droplets in a chimeric model of Alzheimer's disease.
Claes C; Danhash EP; Hasselmann J; Chadarevian JP; Shabestari SK; England WE; Lim TE; Hidalgo JLS; Spitale RC; Davtyan H; Blurton-Jones M
Mol Neurodegener; 2021 Jul; 16(1):50. PubMed ID: 34301296
[TBL] [Abstract][Full Text] [Related]
10. TREM2 regulates purinergic receptor-mediated calcium signaling and motility in human iPSC-derived microglia.
Jairaman A; McQuade A; Granzotto A; Kang YJ; Chadarevian JP; Gandhi S; Parker I; Smith I; Cho H; Sensi SL; Othy S; Blurton-Jones M; Cahalan MD
Elife; 2022 Feb; 11():. PubMed ID: 35191835
[TBL] [Abstract][Full Text] [Related]
11. SHIP inhibition mediates select TREM2-induced microglial functions.
Ramakrishnan GS; Berry WL; Pacherille A; Kerr WG; Chisholm JD; Pedicone C; Humphrey MB
Mol Immunol; 2024 Jun; 170():35-45. PubMed ID: 38613944
[TBL] [Abstract][Full Text] [Related]
12. Activation of FAK/Rac1/Cdc42-GTPase signaling ameliorates impaired microglial migration response to Aβ
Rong Z; Cheng B; Zhong L; Ye X; Li X; Jia L; Li Y; Shue F; Wang N; Cheng Y; Huang X; Liu CC; Fryer JD; Wang X; Zhang YW; Zheng H
FASEB J; 2020 Aug; 34(8):10984-10997. PubMed ID: 32613609
[TBL] [Abstract][Full Text] [Related]
13. Human Induced Pluripotent Stem Cell-Derived Microglia-Like Cells Harboring TREM2 Missense Mutations Show Specific Deficits in Phagocytosis.
Garcia-Reitboeck P; Phillips A; Piers TM; Villegas-Llerena C; Butler M; Mallach A; Rodrigues C; Arber CE; Heslegrave A; Zetterberg H; Neumann H; Neame S; Houlden H; Hardy J; Pocock JM
Cell Rep; 2018 Aug; 24(9):2300-2311. PubMed ID: 30157425
[TBL] [Abstract][Full Text] [Related]
14. Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer's disease.
McQuade A; Kang YJ; Hasselmann J; Jairaman A; Sotelo A; Coburn M; Shabestari SK; Chadarevian JP; Fote G; Tu CH; Danhash E; Silva J; Martinez E; Cotman C; Prieto GA; Thompson LM; Steffan JS; Smith I; Davtyan H; Cahalan M; Cho H; Blurton-Jones M
Nat Commun; 2020 Oct; 11(1):5370. PubMed ID: 33097708
[TBL] [Abstract][Full Text] [Related]
15. The Trem2 R47H Alzheimer's risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans.
Xiang X; Piers TM; Wefers B; Zhu K; Mallach A; Brunner B; Kleinberger G; Song W; Colonna M; Herms J; Wurst W; Pocock JM; Haass C
Mol Neurodegener; 2018 Sep; 13(1):49. PubMed ID: 30185230
[TBL] [Abstract][Full Text] [Related]
16. IPSC-Derived Neuronal Cultures Carrying the Alzheimer's Disease Associated
Martins S; Müller-Schiffmann A; Erichsen L; Bohndorf M; Wruck W; Sleegers K; Van Broeckhoven C; Korth C; Adjaye J
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630447
[TBL] [Abstract][Full Text] [Related]
17. Reduced TREM2 activation in microglia of patients with Alzheimer's disease.
Okuzono Y; Sakuma H; Miyakawa S; Ifuku M; Lee J; Das D; Banerjee A; Zhao Y; Yamamoto K; Ando T; Sato S
FEBS Open Bio; 2021 Nov; 11(11):3063-3080. PubMed ID: 34523252
[TBL] [Abstract][Full Text] [Related]
18. AD-linked R47H-
Sayed FA; Kodama L; Fan L; Carling GK; Udeochu JC; Le D; Li Q; Zhou L; Wong MY; Horowitz R; Ye P; Mathys H; Wang M; Niu X; Mazutis L; Jiang X; Wang X; Gao F; Brendel M; Telpoukhovskaia M; Tracy TE; Frost G; Zhou Y; Li Y; Qiu Y; Cheng Z; Yu G; Hardy J; Coppola G; Wang F; DeTure MA; Zhang B; Xie L; Trajnowski JQ; Lee VMY; Gong S; Sinha SC; Dickson DW; Luo W; Gan L
Sci Transl Med; 2021 Dec; 13(622):eabe3947. PubMed ID: 34851693
[TBL] [Abstract][Full Text] [Related]
19. TREM2 Maintains Microglial Metabolic Fitness in Alzheimer's Disease.
Ulland TK; Song WM; Huang SC; Ulrich JD; Sergushichev A; Beatty WL; Loboda AA; Zhou Y; Cairns NJ; Kambal A; Loginicheva E; Gilfillan S; Cella M; Virgin HW; Unanue ER; Wang Y; Artyomov MN; Holtzman DM; Colonna M
Cell; 2017 Aug; 170(4):649-663.e13. PubMed ID: 28802038
[TBL] [Abstract][Full Text] [Related]
20. Untangling the Role of TREM2 in Conjugation with Microglia in Neuronal Dysfunction: A Hypothesis on a Novel Pathway in the Pathophysiology of Alzheimer's Disease.
Basha SC; Ramaiah MJ; Kosagisharaf JR
J Alzheimers Dis; 2023; 94(s1):S319-S333. PubMed ID: 36683512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]